201 related articles for article (PubMed ID: 24880052)
1. Suberoylanilide hydroxamic acid radiosensitizes tumor hypoxic cells in vitro through the oxidation of nitroxyl to nitric oxide.
Samuni Y; Wink DA; Krishna MC; Mitchell JB; Goldstein S
Free Radic Biol Med; 2014 Aug; 73():291-8. PubMed ID: 24880052
[TBL] [Abstract][Full Text] [Related]
2. The mechanism underlying nitroxyl and nitric oxide formation from hydroxamic acids.
Samuni Y; Samuni U; Goldstein S
Biochim Biophys Acta; 2012 Oct; 1820(10):1560-6. PubMed ID: 22634736
[TBL] [Abstract][Full Text] [Related]
3. The use of cyclic nitroxide radicals as HNO scavengers.
Samuni Y; Samuni U; Goldstein S
J Inorg Biochem; 2013 Jan; 118():155-61. PubMed ID: 23122928
[TBL] [Abstract][Full Text] [Related]
4. The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation.
Samuni Y; Flores-Santana W; Krishna MC; Mitchell JB; Wink DA
Free Radic Biol Med; 2009 Aug; 47(4):419-23. PubMed ID: 19447172
[TBL] [Abstract][Full Text] [Related]
5. One-electron oxidation of acetohydroxamic acid: the intermediacy of nitroxyl and peroxynitrite.
Samuni A; Goldstein S
J Phys Chem A; 2011 Apr; 115(14):3022-8. PubMed ID: 21425838
[TBL] [Abstract][Full Text] [Related]
6. On the distinction between nitroxyl and nitric oxide using nitronyl nitroxides.
Samuni U; Samuni Y; Goldstein S
J Am Chem Soc; 2010 Jun; 132(24):8428-32. PubMed ID: 20504018
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activity of acetohydroxamic acid on prokaryotes under oxidative stress: the role of reactive nitrogen species.
Yadav R; Goldstein S; Nasef MO; Lee W; Samuni U
Free Radic Biol Med; 2014 Dec; 77():291-7. PubMed ID: 25261226
[TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
9. Nitroxides catalytically inhibit nitrite oxidation and heme inactivation induced by H
Samuni A; Maimon E; Goldstein S
Free Radic Biol Med; 2016 Dec; 101():491-499. PubMed ID: 27826125
[TBL] [Abstract][Full Text] [Related]
10. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
[TBL] [Abstract][Full Text] [Related]
11. Redox generation of nitric oxide to radiosensitize hypoxic cells.
Mitchell JB; DeGraff W; Kim S; Cook JA; Gamson J; Christodoulou D; Feelisch M; Wink DA
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):795-8. PubMed ID: 9845098
[TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase Inhibitor Induced Radiation Sensitization Effects on Human Cancer Cells after Photon and Hadron Radiation Exposure.
Gerelchuluun A; Maeda J; Manabe E; Brents CA; Sakae T; Fujimori A; Chen DJ; Tsuboi K; Kato TA
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414878
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure.
Qiu X; Rong X; Yang J; Lu Y
BMC Ophthalmol; 2019 Feb; 19(1):42. PubMed ID: 30717701
[TBL] [Abstract][Full Text] [Related]
14. Piloty's acid derivative with improved nitroxyl-releasing characteristics.
Aizawa K; Nakagawa H; Matsuo K; Kawai K; Ieda N; Suzuki T; Miyata N
Bioorg Med Chem Lett; 2013 Apr; 23(8):2340-3. PubMed ID: 23489625
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory properties of histone deacetylase inhibitors: a mechanistic study.
Chong W; Li Y; Liu B; Liu Z; Zhao T; Wonsey DR; Chen C; Velmahos GC; deMoya MA; King DR; Kung AL; Alam HB
J Trauma Acute Care Surg; 2012 Feb; 72(2):347-53; discussion 353-4. PubMed ID: 22327976
[TBL] [Abstract][Full Text] [Related]
16. In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model.
Thiemann M; Oertel S; Ehemann V; Weichert W; Stenzinger A; Bischof M; Weber KJ; Perez RL; Haberkorn U; Kulozik AE; Debus J; Huber PE; Battmann C
Radiat Oncol; 2012 Mar; 7():52. PubMed ID: 22458853
[TBL] [Abstract][Full Text] [Related]
17. Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation.
Blattmann C; Oertel S; Thiemann M; Weber KJ; Schmezer P; Zelezny O; Lopez Perez R; Kulozik AE; Debus J; Ehemann V
Strahlenther Onkol; 2012 Feb; 188(2):168-76. PubMed ID: 22249335
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of HRP-catalyzed nitrite oxidation by H
Samuni A; Maimon E; Goldstein S
Free Radic Biol Med; 2017 Jul; 108():832-839. PubMed ID: 28495446
[TBL] [Abstract][Full Text] [Related]
19. A novel suberoylanilide hydroxamic acid histone deacetylase inhibitor derivative, N25, exhibiting improved antitumor activity in both human U251 and H460 cells.
Zhang S; Huang WB; Wu L; Wang LY; Ye LB; Feng BH
Asian Pac J Cancer Prev; 2014; 15(10):4331-8. PubMed ID: 24935393
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome c/H2O2-mediated one electron oxidation of carcinogenic N-fluorenylacetohydroxamic acids to nitroxyl free radicals.
Ritter CL; Malejka-Giganti D; Polnaszek CF
Chem Biol Interact; 1983 Sep; 46(3):317-34. PubMed ID: 6315247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
